Literature DB >> 15604419

Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.

Annong Huang1, Ying-Yi Zhang, Kai Chen, Kazuyuki Hatakeyama, John F Keaney.   

Abstract

Endothelial production of nitric oxide (NO) is dependent on adequate cellular levels of tetrahydrobiopterin (BH4), an important cofactor for the nitric oxide synthases. Vascular diseases are often characterized by vessel wall inflammation and cytokine treatment of endothelial cells increases BH4 levels, in part through the induction of GTP cyclohydrolase I (GTPCH I), the rate-limiting enzyme for BH4 biosynthesis. However, the molecular mechanisms of cytokine-mediated GTPCH I induction in the endothelium are not entirely clear. We sought to investigate the signaling pathways whereby cytokines induce GTPCH I expression in human umbilical vein endothelial cells (HUVECs). Interferon-gamma (IFN-gamma) induced endothelial cell GTPCH I protein and BH4 modestly, whereas high-level induction required combinations of IFN-gamma and tumor necrosis factor-alpha (TNF-alpha). In the presence of IFN-gamma, TNF-alpha increased GTPCH I mRNA in a manner dependent on nuclear factor-kappaB (NF-kappaB), as this effect was abrogated by overexpression of a dominant-negative IkappaB construct. HUVEC IFN-gamma treatment resulted in signal transducer and activator of transcription 1 (Stat1) activation and DNA binding in a Jak2-dependent manner, as this was inhibited by AG490. Conversely, overexpression of Jak2 effectively substituted for IFN-gamma in supporting TNF-alpha-mediated GTPCH I induction. The role of IFN-gamma was also Stat1-dependent as Stat1-null cells exhibited no GTPCH I induction in response to cytokines. However, Stat1 activation with oncostatin M failed to support TNF-alpha-mediated GTPCH I induction because of concomitant Stat3 activation. Consistent with this notion, siRNA-mediated Stat3 gene silencing allowed oncostatin M to substitute for IFN-gamma in this system. These data implicate both NF-kappaB and Stat1 in endothelial cell cytokine-stimulated GTPCH I induction and highlight the role of Stat3 in modulating Stat1-supported gene transcription. Thus, IFN-gamma and TNF-alpha exert distinct but cooperative roles for BH4 biosynthesis in endothelium that may have important implications for vascular function during vascular inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604419     DOI: 10.1161/01.RES.0000153669.24827.DF

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin.

Authors:  Tongrong He; Leslie A Smith; Tong Lu; Michael J Joyner; Zvonimir S Katusic
Journal:  Hypertension       Date:  2011-06-27       Impact factor: 10.190

2.  PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway.

Authors:  Zihui Zhang; Xinya Xie; Qinyu Yao; Jia Liu; Ying Tian; Chunmiao Yang; Lei Xiao; Nanping Wang
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

3.  Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways.

Authors:  Mark J Crabtree; Amy L Tatham; Ashley B Hale; Nicholas J Alp; Keith M Channon
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

4.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Shuxun Ren; E Rene Rodriguez; Barbara Tavazzi; Giuseppe Lazzarino; Nazareno Paolocci; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

Review 5.  Tetrahydrobiopterin, superoxide, and vascular dysfunction.

Authors:  Jeannette Vásquez-Vivar
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

6.  GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function.

Authors:  Charalambos Antoniades; Cheerag Shirodaria; Tim Van Assche; Colin Cunnington; Irmgard Tegeder; Jörn Lötsch; Tomasz J Guzik; Paul Leeson; Jonathan Diesch; Dimitris Tousoulis; Christodoulos Stefanadis; Michael Costigan; Clifford J Woolf; Nicholas J Alp; Keith M Channon
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

7.  Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes.

Authors:  Irina A Ionova; Jeannette Vásquez-Vivar; Jennifer Whitsett; Anja Herrnreiter; Meetha Medhora; Brian C Cooley; Galen M Pieper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

8.  Inhibition of CDKS by roscovitine suppressed LPS-induced *NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages.

Authors:  Jianhai Du; Na Wei; Tongju Guan; Hao Xu; Jianzhong An; Kirkwood A Pritchard; Yang Shi
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-24       Impact factor: 4.249

9.  Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.

Authors:  Laura Stevenson; Nuria Matesanz; Liza Colhoun; Kevin Edgar; Adrian Devine; Tom A Gardiner; Denise M McDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

10.  In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2009-06-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.